Published in Health Econ on June 01, 2004
Calculation of costs of pregnancy- and puerperium-related care: experience from a hospital in a low-income country. J Health Popul Nutr (2010) 1.19
Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43
Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg (2004) 8.13
What can be done about the private health sector in low-income countries? Bull World Health Organ (2002) 4.87
Maternal health in poor countries: the broader context and a call for action. Lancet (2006) 4.72
Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg (2007) 4.51
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
Health financing to promote access in low income settings-how much do we know? Lancet (2004) 4.31
Achieving universal coverage with health interventions. Lancet (2004) 4.29
The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission. Lancet (2010) 4.24
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ (2008) 4.02
Improving the health of the global poor. Science (2002) 3.69
Building the field of health policy and systems research: an agenda for action. PLoS Med (2011) 3.54
Mobilising financial resources for maternal health. Lancet (2006) 3.53
Building the field of health policy and systems research: social science matters. PLoS Med (2011) 3.46
The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg (2007) 3.44
Assessing capacity for health policy and systems research in low and middle income countries* Health Res Policy Syst (2003) 3.29
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health (2004) 3.22
Building the field of health policy and systems research: framing the questions. PLoS Med (2011) 3.21
Health-financing reforms in southeast Asia: challenges in achieving universal coverage. Lancet (2011) 3.14
Financing of health systems to achieve the health Millennium Development Goals in low-income countries. Lancet (2010) 3.10
To retain or remove user fees?: reflections on the current debate in low- and middle-income countries. Appl Health Econ Health Policy (2006) 3.06
Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J (2011) 2.99
Scaling up in international health: what are the key issues? Health Policy Plan (2010) 2.96
Costs and consequences of large-scale vector control for malaria. Malar J (2008) 2.93
Is malaria a disease of poverty? A review of the literature. Trop Med Int Health (2005) 2.88
Countdown to 2015: assessment of donor assistance to maternal, newborn, and child health between 2003 and 2006. Lancet (2008) 2.83
Is private health care the answer to the health problems of the world's poor? PLoS Med (2008) 2.82
The economic impact of malaria in Africa: a critical review of the evidence. Health Policy (2003) 2.42
Which delivery systems reach the poor? A review of equity of coverage of ever-treated nets, never-treated nets, and immunisation to reduce child mortality in Africa. Lancet Infect Dis (2005) 2.39
Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health Policy Plan (2007) 2.35
Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003-08. Lancet (2010) 2.33
What can global health institutions do to help strengthen health systems in low income countries? Health Res Policy Syst (2010) 2.31
Scaling-up and sustaining insecticide-treated net coverage. Lancet Infect Dis (2003) 2.27
Cost-effectiveness of social marketing of insecticide-treated nets for malaria control in the United Republic of Tanzania. Bull World Health Organ (2003) 2.26
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Inequalities in purchase of mosquito nets and willingness to pay for insecticide-treated nets in Nigeria: challenges for malaria control interventions. Malar J (2004) 2.23
Do malaria control interventions reach the poor? A view through the equity lens. Am J Trop Med Hyg (2004) 2.23
Dual job holding by public sector health professionals in highly resource-constrained settings: problem or solution? Bull World Health Organ (2005) 2.22
Employment preferences of public sector nurses in Malawi: results from a discrete choice experiment. Trop Med Int Health (2008) 2.20
Countdown to 2015: tracking donor assistance to maternal, newborn, and child health. Lancet (2006) 2.08
Costs and effects of the Tanzanian national voucher scheme for insecticide-treated nets. Malar J (2008) 2.07
Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial. PLoS Med (2009) 2.05
The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J (2011) 2.03
How to do (or not to do) ... Designing a discrete choice experiment for application in a low-income country. Health Policy Plan (2008) 2.01
From Mexico to Mali: progress in health policy and systems research. Lancet (2008) 1.99
Reproductive health priorities: evidence from a resource tracking analysis of official development assistance in 2009 and 2010. Lancet (2013) 1.95
Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv Res (2009) 1.95
Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malar J (2009) 1.94
Delivery systems for insecticide treated and untreated mosquito nets in Africa: categorization and outcomes achieved. Health Policy Plan (2007) 1.92
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J (2008) 1.90
What do we mean by rigorous health-systems research? Lancet (2008) 1.89
Scaling up priority health interventions in Tanzania: the human resources challenge. Health Policy Plan (2007) 1.86
Countdown to 2015: changes in official development assistance to maternal, newborn, and child health in 2009-10, and assessment of progress since 2003. Lancet (2012) 1.86
Costing the distribution of insecticide-treated nets: a review of cost and cost-effectiveness studies to provide guidance on standardization of costing methodology. Malar J (2006) 1.73
Health policy and systems research: defining the terrain; identifying the methods. Health Policy Plan (2011) 1.72
Intervention complexity--a conceptual framework to inform priority-setting in health. Bull World Health Organ (2005) 1.72
Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria. Trop Med Int Health (2009) 1.72
Assessment of a national voucher scheme to deliver insecticide-treated mosquito nets to pregnant women. CMAJ (2010) 1.71
Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth (2014) 1.70
Which family members use the best nets? An analysis of the condition of mosquito nets and their distribution within households in Tanzania. Malar J (2010) 1.67
Malaria eradication: the economic, financial and institutional challenge. Malar J (2008) 1.62
Learning from Thailand's health reforms. BMJ (2004) 1.61
An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines. Health Aff (Millwood) (2009) 1.59
Promoting universal financial protection: how the Thai universal coverage scheme was designed to ensure equity. Health Res Policy Syst (2013) 1.58
Horizontal equity in utilisation of care and fairness of health financing: a comparison of micro-health insurance and user fees in Rwanda. Health Econ (2006) 1.57
Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania. Malar J (2008) 1.55
Cost of increasing access to artemisinin combination therapy: the Cambodian experience. Malar J (2008) 1.55
The household costs of health care in rural South Africa with free public primary care and hospital exemptions for the poor. Trop Med Int Health (2009) 1.49
The Affordable Medicines Facility--malaria: killing it slowly. Lancet (2012) 1.47
Classical versus relational approaches to understanding controls on a contract with independent GPs in South Africa. Health Econ (2003) 1.45
Cost-effectiveness of malaria control interventions when malaria mortality is low: insecticide-treated nets versus in-house residual spraying in India. Soc Sci Med (2004) 1.37
Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J (2013) 1.37
The role of regulation in influencing income-generating activities among public sector doctors in Peru. Hum Resour Health (2007) 1.30
A review of health resource tracking in developing countries. Health Policy Plan (2007) 1.30
Donor funding for newborn survival: an analysis of donor-reported data, 2002-2010. PLoS Med (2012) 1.27
The economics of malaria in pregnancy--a review of the evidence and research priorities. Lancet Infect Dis (2007) 1.27
Some indicators of socio-economic status may not be reliable and use of indices with these data could worsen equity. Health Econ (2006) 1.27
Do poor people use poor quality providers? Evidence from the treatment of presumptive malaria in Nigeria. Trop Med Int Health (2011) 1.26
Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Health Econ (2009) 1.25
Examining catastrophic health expenditures at variable thresholds using household consumption expenditure diaries. Trop Med Int Health (2011) 1.25
Taskforce on Innovative International Financing for Health Systems: showing the way forward. Bull World Health Organ (2010) 1.23
Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics (2009) 1.23
Methods for studying private sector supply of public health products in developing countries: a conceptual framework and review. Soc Sci Med (2003) 1.22
From intervention to impact: modelling the potential mortality impact achievable by different long-lasting, insecticide-treated net delivery strategies. Malar J (2012) 1.19
Examining inequities in incidence of catastrophic health expenditures on different healthcare services and health facilities in Nigeria. PLoS One (2012) 1.18
A cost function for HIV prevention services: is there a 'u' - shape? Cost Eff Resour Alloc (2007) 1.18
Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences. Malar J (2012) 1.16
Who buys insecticide-treated nets? Implications for increasing coverage in Nigeria. Health Policy Plan (2003) 1.14
Methods for evaluating delivery systems for scaling-up malaria control intervention. BMC Health Serv Res (2010) 1.13
The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. Malar J (2008) 1.13
Financial incentives for maternal health: impact of a national programme in Nepal. J Health Econ (2011) 1.12
The use of discrete choice experiments to inform health workforce policy: a systematic review. BMC Health Serv Res (2014) 1.11